Home » Topics » Regulatory

Regulatory
RSS

Lev receives FDA approval for Cinryze in hereditary angioedema prophylaxis

Oct. 13, 2008

FDA approves Bayer HealthCare's Kogenate for prophylaxis in hemophilia A

Oct. 13, 2008

Santhera launches Catena in Canada for Friedreich's ataxia

Oct. 10, 2008

FDA approves Akten ophthalmic gel 3.5%

Oct. 9, 2008

European Commission adopts EMEA recommendations for Arcoxia 90 mg

Oct. 2, 2008

Aclasta approved in Europe for osteoporosis in men with high risk of fractures

Oct. 1, 2008

CHMP issues positive opinion for olanzapine long-acting injection in schizophrenia

Sep. 29, 2008

Xarelto approved in Canada for prevention of venous thromboembolic events

Sep. 17, 2008

FDA approves Gamunex for inflammatory demyelinating polyneuropathy

Sep. 17, 2008

Vimpat approved in the E.U. for partial-onset seizures

Sep. 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...